Abstract
HIV is the most significant risk factor for many opportunistic infections like fungal, tuberculosis, etc. The intense media coverage of AIDS puts the public on an emotional roller caster, and inflated promises are engendered by each success. For the moment drugs acting as both HIV-reverse transcriptase inhibitors along with antimicrobial properties are one of the brightest hope. The Non-nucleoside reverse transcriptase inhibitors (NNRTIs) appear ideally suited for further development in the chemoprophylaxis and therapy of HIV infections. In recent years, isatinimino compounds have been reported to exhibit broad-spectrum chemotherapeutic properties that include anti-HIV, antituberculous, antifungal and antibacterial activities. Hence these leads should be regarded as structural hits in the search for more potent antimicrobial compounds with broad-spectrum chemotherapeutic properties for the effective treatment of HIV / AIDS. This review focuses on the design of isatinimino compounds, which resemble the NNRTIs for the development of an ideal anti-HIV drug.
Keywords: broad spectrum chemotherapeutic, hiv, aids, opportunistic infections, hiv-reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors
Current Medicinal Chemistry
Title: Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDS
Volume: 10 Issue: 17
Author(s): Dharmarajan Sriram and Perumal Yogeeswari
Affiliation:
Keywords: broad spectrum chemotherapeutic, hiv, aids, opportunistic infections, hiv-reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors
Abstract: HIV is the most significant risk factor for many opportunistic infections like fungal, tuberculosis, etc. The intense media coverage of AIDS puts the public on an emotional roller caster, and inflated promises are engendered by each success. For the moment drugs acting as both HIV-reverse transcriptase inhibitors along with antimicrobial properties are one of the brightest hope. The Non-nucleoside reverse transcriptase inhibitors (NNRTIs) appear ideally suited for further development in the chemoprophylaxis and therapy of HIV infections. In recent years, isatinimino compounds have been reported to exhibit broad-spectrum chemotherapeutic properties that include anti-HIV, antituberculous, antifungal and antibacterial activities. Hence these leads should be regarded as structural hits in the search for more potent antimicrobial compounds with broad-spectrum chemotherapeutic properties for the effective treatment of HIV / AIDS. This review focuses on the design of isatinimino compounds, which resemble the NNRTIs for the development of an ideal anti-HIV drug.
Export Options
About this article
Cite this article as:
Sriram Dharmarajan and Yogeeswari Perumal, Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDS, Current Medicinal Chemistry 2003; 10 (17) . https://dx.doi.org/10.2174/0929867033457142
DOI https://dx.doi.org/10.2174/0929867033457142 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Dynamics Simulations, Challenges and Opportunities: A Biologist’s Prospective
Current Protein & Peptide Science Design, Synthesis and Biological Evaluation of Carbazole Derivatives as Antitubercular and Antibacterial Agents
Current Bioactive Compounds Phytochemical and Biological Activities of an Anticancer Plant Medicine: Brucea javanica
Anti-Cancer Agents in Medicinal Chemistry Nano-Precipitation: Preparation and Application in the Field of Pharmacy
Current Pharmaceutical Design Anti-Arthritic Effects of Immunomodulatory Peptide Injected in Joints
Current Drug Delivery A QSAR Study of Biphenyl Analogues of 2-Nitroimidazo-[2, 1-b] [1, 3] - oxazines as Antitubercular Agents Using Genetic Function Approximation
Medicinal Chemistry Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges
Recent Patents on Anti-Infective Drug Discovery The Inhibition of 5-enolpyruvylshikimate-3-phosphate Synthase as a Model for Development of Novel Antimicrobials
Current Drug Targets Medicinal Botanicals in the Traditional Medicine of the Veps Used for Bronchial Infections
Current Traditional Medicine Recent Advances of Fluorescent Technologies for Drug Discovery and Development
Current Pharmaceutical Design Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Current Protein & Peptide Science Foreword
Recent Patents on Anti-Infective Drug Discovery Benzocaine: Review on a Drug with Unfold Potential
Mini-Reviews in Medicinal Chemistry Medicinal Plants for the Prevention and Treatment of Bacterial Infections
Current Pharmaceutical Design Chronic Granulomatous Disease in Childhood
Current Pediatric Reviews Meet Our Editorial Board Member:
Current Pharmaceutical Biotechnology Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Lipoplexes Formulation and Optimisation: In Vitro Transfection Studies Reveal No Correlation with In Vivo Vaccination Studies
Current Drug Delivery Regulation and Function of Antimicrobial Peptides in Immunity and Diseases of the Lung
Protein & Peptide Letters